Related Experiment Video
Updated: Jun 10, 2025
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
Exploring the interaction mechanisms between cervical carcinoma in situ and antibody-mediated immune responses
Junfei Li1, Lihuang He2, Qun He3
1Department of Gynecology, Affiliated Hospital (Clinical College) of Xiangnan University, Chenzhou, 423000, People's Republic of China.
Insights
This study reveals a two-way causal link between antibody-mediated immune responses and cervical carcinoma in situ. Findings support new strategies for preventing and treating cervical carcinoma in situ by understanding immune system interactions.
Area of Science:
- Immunology
- Oncology
- Genetics
Background:
- Cervical carcinoma in situ (CIS) is a precursor to invasive cervical cancer.
- Understanding the interplay between immune responses and CIS is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the causal relationship between antibody-mediated immune responses and cervical carcinoma in situ.
- To provide a scientific basis for the prevention and treatment of cervical carcinoma in situ.
Main Methods:
- Utilized a bidirectional Mendelian Randomization (MR) approach.
- Employed Genome-Wide Association Studies (GWAS) data for cervical carcinoma in situ and antibody-mediated immune responses.
- Applied multiple statistical methods including inverse-variance weighted (IVW), MR-Egger regression, weighted median, and weighted mode.
Main Results:
- Forward MR analysis identified significant causal associations between specific SNPs in antibody-mediated immune responses and cervical carcinoma in situ.
- Reverse MR analysis indicated that cervical carcinoma in situ influences multiple SNPs related to antibody-mediated immune responses.
- Several SNPs showed significant positive or distinct trends of influence in both forward and reverse analyses.
Conclusions:
- Confirmed a clear bidirectional causal relationship between antibody-mediated immune responses and cervical carcinoma in situ.
- Elucidated interaction mechanisms between immune responses and cervical carcinoma in situ.
- Suggested potential avenues for developing targeted prevention and control strategies for cervical carcinoma in situ.
Objective:
This study aims to investigate the causal relationship between cervical carcinoma in situ and antibody-mediated immune responses, providing a scientific basis for the prevention and treatment of cervical carcinoma in situ.
Methods:
A bidirectional Mendelian Randomization (MR) approach was utilized, leveraging two Genome-Wide Association Studies (GWAS) related to cervical carcinoma in situ and antibody-mediated immune responses to collect Single Nucleotide Polymorphism (SNP) data. Multiple statistical methods, including the inverse-variance weighted (IVW) method, MR-Egger regression, weighted median, and weighted mode, were utilized. Antibody-mediated immune response-related SNPs were used as instrumental variables (IVs) for a forward MR analysis of cervical carcinoma in situ, while cervical carcinoma in situ-related SNPs served as IVs for a reverse MR analysis of antibody-mediated immune responses.
Results:
The forward MR analysis revealed significant causal associations between two SNPs, GCST90006901 (P = 0.012, OR (95%CI) = 1.167(1.034-1.317)) and GCST90006909 (P < 0.001, OR (95%CI) = 1.805(1.320-2.467)), within antibody-mediated immune responses and the occurrence of cervical carcinoma in situ. The reverse MR analysis demonstrated that cervical carcinoma in situ exerts influence on multiple SNPs associated with antibody-mediated immune responses. Specifically, GCST90006891 (P = 0.018, OR (95%CI) = 1.164(1.027-1.319)) and GCST90006894 (P = 0.048, OR (95%CI) = 1.074 (1.001-1.153)) showed positive effects, while GCST90006899 (P = 0.022, OR (95%CI) = 0.935(0.882-0.990)) and GCST90006911 (P = 0.0193, OR (95%CI) = 1.226(1.034-1.454)) exhibited distinct trends of influence.
Conclusion:
The Mendelian Randomization analysis indicates a clear causal relationship between antibody-mediated immune responses and the prevalence of cervical carcinoma in situ, with cervical carcinoma in situ also exerting a certain degree of influence on antibody-mediated immune responses. This finding provides important insights into the interaction mechanism between the two and suggests avenues for developing effective prevention and control strategies.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
01:20Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...